Cargando…

1194. Carbapenem-Resistant Enterobacteriaceae in Kentucky: Initial 6 Months of Mechanism Testing

BACKGROUND: A global rise in carbapenem-resistant Enterobacteriaceae (CRE) has been noted over the past two decades. State and local data on CRE are necessary to better inform public health interventions. METHODS: Reporting of CRE (i.e., Enterobacteriaceae resistant to any carbapenem or shown to pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spicer, Kevin, Cox, Katelyn, Zinner, Rachel, Flinchum, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252512/ http://dx.doi.org/10.1093/ofid/ofy210.1027

Ejemplares similares

704. Klebsiella pneumoniae Carbapenemase and Verona Integron-Encoded Metallo-β-Lactamase Among Carbapenem-Resistant Enterobacteriaceae in Kentucky
por: Spicer, Kevin, et al.
Publicado: (2018)

Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Among Patients Without Usual Risk Factors—Kentucky, 2016
por: Yaffee, Anna, et al.
Publicado: (2017)

138. Description of Repeat Carbapenem-resistant Enterobacterales (CRE) Submitted to a State Laboratory from the Same Individuals, Kentucky - December 2018 - March 2022
por: Spicer, Kevin B, et al.
Publicado: (2022)

Notes from the Field: Investigation of Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Among Patients at a Community Hospital — Kentucky, 2016
por: Chae, Sae-Rom, et al.
Publicado: (2018)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

1194. Gender Differences in Psychosocial Determinants of Hand Hygiene Among Doctors
por: Park, Sunghee, et al.
Publicado: (2019)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

EP1194: THE PROGNOSTIC IMPLICATIONS OF LIVER FUNCTION TEST ABNORMALITIES IN PATIENTS ADMITTED TO HOSPITAL WITH COVID-19
por: Cohen, Jason, et al.
Publicado: (2022)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

Inappropriate Prescribing of Antibiotics to Pediatric Patients Receiving Medicaid: Comparison of High-Volume and Non-High-Volume Antibiotic Prescribers—Kentucky, 2019
por: Wattles, Bethany A., et al.
Publicado: (2023)

1194. Identification and Characterization of Extracellular Inducers of Persistence in Staphylococcus epidermidis and Staphylococcus aureus
por: Habtu, Danni Y, et al.
Publicado: (2020)

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam
por: Rahmati, Elham, et al.
Publicado: (2017)

2411. Expanded Susceptibility and Resistance Mechanism Testing Among Carbapenem-Resistant Enterobacteriaceae in Connecticut, 2017
por: Durante, Amanda, et al.
Publicado: (2018)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

1194. Implementation of Methicillin-Resistant Staphylococcus Aureus Nasal Swabs as an Antimicrobial Stewardship Tool in a Community Hospital
por: Gibson, Heather D, et al.
Publicado: (2023)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Germicidal Activity against Carbapenem/Colistin-resistant Enterobacteriaceae Using a Quantitative Carrier Test Method
por: Kanamori, Hajime, et al.
Publicado: (2017)

537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Campbell, Eileen, et al.
Publicado: (2019)

2446. Clinical Spectrum and Outcomes of Colistin-Resistant Carbapenem-Resistant Enterobacteriaceae
por: Ahmed, Sara, et al.
Publicado: (2018)

1249. Emergence of Diverse Carbapenem-Resistant Enterobacteriaceae (CRE) in the Dominican Republic
por: Fermin, Rita Rojas, et al.
Publicado: (2018)

621. In vitro Ceftazidime: Avibactam Resistance in Carbapenem-Resistant Enterobacteriaceae Isolates
por: Belal, Maymonah, et al.
Publicado: (2019)

1452. Is Carbapenem-Sparing Therapy as Effective as Carbapenems Against Extended-Spectrum β-Lactamase Producing Enterobacteriaceae in UTI?
por: Hyun, Jonghoon, et al.
Publicado: (2019)

710. In Vitro Activity and Performance of Available Susceptibility Testing Methods for Eravacycline Against Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Jones, Chelsea E, et al.
Publicado: (2019)

843. Increased Carbapenemase Testing Following Implementation of VA Guidelines for Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Fitzpatrick, Margaret A, et al.
Publicado: (2020)

1457. Serial Passage of Enterobacteriaceae to Explore Development of Carbapenem Resistance
por: Nissim, Yosef, et al.
Publicado: (2020)

Factors Associated with Mortality in Carbapenem-Resistant Enterobacteriaceae Bacteremia: Focus on Antibiotic Therapy
por: Pillinger, Kelly E, et al.
Publicado: (2017)

533. Impact of Different Definitions on Reported Rates of Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Passaretti, Catherine, et al.
Publicado: (2019)

2145. Carbapenem-Resistant Enterobacteriaceae infections at the Maharaj Nakorn Chiang Mai Hospital
por: Chaiwarith, Romanee, et al.
Publicado: (2019)

509. The Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) in a Community Hospital Setting
por: Lewis, Sally, et al.
Publicado: (2019)

417. Factors associated with 30-day Mortality in Carbapenems-resistant Enterobacteriaceae Infections
por: Osaithai, Naphol, et al.
Publicado: (2022)

708. Incidence and Relatedness of Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Infections in Previously Colonized or Infected Patients
por: Tang, Sarah Si Lin, et al.
Publicado: (2018)

Carbapenem Resistant Enterobacteriaceae infections in Houston, Texas: An outline
por: Rehman, Hafeez, et al.
Publicado: (2017)

1251. Contaminated Sinks May be an Environmental Source for Serial Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE) to ICU Patients
por: Lewis, Sarah S, et al.
Publicado: (2018)

Aminoglycoside Susceptibility Agreement between an Automated System and Broth Microdilution for Carbapenem-resistant Enterobacteriaceae
por: Kulengowski, Brandon, et al.
Publicado: (2017)

2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017
por: Snayd, Mary, et al.
Publicado: (2018)

631. Laboratory Surveillance of Carbapenem-Resistant Enterobacteriaceae in an Endemic Country, Greece, 2015–2018
por: Tryfinopoulou, Kyriaki, et al.
Publicado: (2019)

1178. A Multicenter Prospective Study of Clinical and Molecular Epidemiological Analysis of Carbapenem-Resistant Enterobacteriaceae (CRE) and Carbapenemase-Producing Enterobacteriaceae (CPE) in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2018)

Use of the Extensively Drug-resistant Organism (XDRO) Registry for Carbapenem-Resistant Enterobacteriaceae (CRE) Reporting and Initiation of Transmission Precautions — Chicago, Illinois, 2016
por: Kerins, Janna L, et al.
Publicado: (2017)

2247. Real-world Experience with Meropenem–Vaborbactam (M/V) for Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Shields, Ryan K, et al.
Publicado: (2019)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_imek1c7lkef6gj8k8mu68u1srj